ZIMMER BIOMET HOLDINGS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2025-02-25
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-12-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-09-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2023-03-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2024 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2022 was -$71.50M.
- ZIMMER BIOMET HOLDINGS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2020 was $128.90M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $0.00 10-Q · filed 2023-08-01 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $7.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $7.00M derived: sum of 3 quarters · filed 2025-02-25 | -$71.50M 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $7.00M derived: sum of 2 quarters · filed 2023-11-07 | -$71.50M 10-Q · filed 2023-11-07 | -$43.40M derived: sum of 4 quarters · filed 2024-08-07 |
| 2022-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$71.50M 10-Q · filed 2023-08-01 | -$43.40M derived: sum of 3 quarters · filed 2024-08-07 | -$34.50M derived: sum of 4 quarters · filed 2024-08-07 |
| 2022-03-31 | -$78.50M 10-Q · filed 2023-05-02 | -$50.40M derived: sum of 2 quarters · filed 2024-08-07 | -$41.50M derived: sum of 3 quarters · filed 2024-08-07 | -$6.60M derived: sum of 4 quarters · filed 2024-08-07 |
| 2021-12-31 | $28.10M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $37.00M derived: sum of 2 quarters · filed 2024-08-07 | $71.90M derived: sum of 3 quarters · filed 2024-08-07 | $94.90M 8-K · filed 2024-08-07 |
| 2021-09-30 | $8.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $43.80M derived: sum of 2 quarters · filed 2022-11-02 | $66.80M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $34.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $57.90M 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | $23.00M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $128.90M 10-K · filed 2023-02-24 | |||
| 2019-12-31 | $196.00M 8-K · filed 2022-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |